Tabula Rasa HealthCare, Inc., a leading healthcare technology company, has announced the appointment of Brian Adams as president and CEO. Adams, who was serving as TRHC’s interim CEO since September 2022 and previously served as the company’s co-president and chief financial officer, was also appointed to the company’s Board of Directors as a Class I director, effective immediately.
TRHC also announced that Richard W. Rew II has joined the company as chief legal officer and corporate secretary, effective April 10, 2023. Rew joins the company from IsoPlexis Corporation, where he served as senior vice president, general counsel and secretary. As chief legal officer, Rew will be responsible for legal operations, litigation, corporate governance, and regulatory affairs of the company.
Michael Purcell, TRHC chairman, commented: “As interim CEO, Brian has brought stability to the organization and laid a strong foundation for both profitable growth and long-term value creation. Thanks to his deep industry experience and strong knowledge of our primary target markets, in particular the Program of All-Inclusive Care for the Elderly (PACE), he has also earned the respect of our clients, partners, team members and shareholders. The Board’s decision to appoint Brian as CEO reflects its commitment to fostering a high-performing management team and retaining, rewarding and developing TRHC’s own talent. We firmly believe Brian is the right leader as we embark on the next chapter for the Company.”
Adams commented, “I greatly appreciate the Board’s trust and belief in me, and I am honored to continue working alongside a talented management team and dedicated employee base. Over the past few months, we have made significant strides refocusing our business around our solutions for PACE, our fastest growing market, and we are committed to advancing these offerings in order to support future growth and enhance our client experience. Our combination of solutions is not only relevant in PACE, but also to adjacent healthcare markets taking on financial risk and serving similar demographics and I am excited to capitalize on these opportunities. The Board and the leadership team are confident in our current market position and look forward to keeping the momentum going as we continue to make positive impacts on patient care for our clients.”
To access more business news, visit NJB News Now.Related Articles: